Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies, GeneSeek Settle Patent Dispute

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has reached a settlement and licensing agreement with GeneSeek, resolving a patent dispute between the firms.

Genetic Technologies is granting GeneSeek non-exclusive rights to a number of its patents pertaining to non-coding DNA technology. Other terms were not disclosed.

GeneSeek, a Neogen company that provides agrigenomic and veterinary products and services, was one of 10 firms sued by Genetic Technologies in May 2011 for alleged infringement of US Patent No. 5,612,179, titled "Intron Sequence Analysis Method for Detection of Adjacent Locus Alleles as Haplotypes."

Along with Neogen/GeneSeek, the firms named in the lawsuit were Agilent Technologies; Bristol-Myers Squibb; Eurofins STA Laboratories; GlaxoSmithKline; Hologic; Merial; Navigenics; Pfizer; and 454 Life Sciences.

GeneSeek is the fourth firm to settle with Genetic Technologies, the Australian genetic test development firm said. It previously reached deals with Navigenics, Hologic, and Eurofins. Discussions with other companies named in the lawsuit are ongoing and progressing, Genetic Technologies added.

The Scan

Booster for Kids

The US Food and Drug Administration has authorized a booster dose of Pfizer-BioNTech's SARS-CoV-2 vaccine for 5-to-11-year olds, the Washington Post reports.

Novavax Anticipates Authorization

Novavax expects to receive US Food and Drug Administration authorization for vaccine soon, according to CNBC.

Some Old Microbes Indeed

Vice reports that researchers may have uncovered 830-million-year-old microbes.

PNAS Papers on Meiotic Crossover, RNA Targeting, SNAT7 mTORC1 Regulation

In PNAS this week: meiotic crossover formation in C. elegans, approach to identify small molecules affecting RNA activity, and more.